A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin®) Vaccine in Healthy US Adults.
Carol M KaoChristina A RostadLauren E NolanEtza PetersJennifer KleinhenzJacob D ShermanAshley TippettJ Wai Kuo ShihInci YildirimVivien AgbakobaTatiana BeresnevCassandra BallouSatoshi KamidaniVinit KarmaliMuktha NatrajanErin M SchererNadine G RouphaelEvan J AndersonPublished in: The Journal of infectious diseases (2024)
NCT03827395. Safety Study of Hepatitis E Vaccine (HEV239) - Full Text View - ClinicalTrials.gov.